The legislative reform being prepared by the EU plans to promote the use of already approved drugs for new ailments. This route allows to accelerate the approval of treatments and save costs in research.
Read the comment of our Director general and full Article below
Adrian van den Hoven, chair of the International Generic and Biosimilar Medicines Association (IGBA), which aims to foster market access for generic medicines, said that the evergreening of patent agreements artificially stretches monopolies and harms access to medicines.
Read the full Article below
Background: Price erosion of generic medicines over time as a result of existing pricing policies in combination with increasing operational costs of these products due to high inflation, undermine long-term sustainable competition in European off-patent medicines markets. Therefore, the aim of this study is to identify new potential pricing models for retail generic medicines in Europe, examine their pros and cons, and illustrate them with examples inside or outside the pharmaceutical sector.
Antradienį Vyriausybės kanclerė Giedrė Balčytytė susitiko su organizacijos „Medicine for Europe“ generaliniu direktoriumi Adrianu van den Hovenu, su kuriuo aptarė Europoje ir pasaulyje pastaruoju metu stebimus vaistų tiekimo sutrikimus ir būtinybę užtikrinti vaistų prieinamumą pacientams. Kaip pabrėžė kanclerė, Lietuvos Vyriausybė laiko prioritetu vaistų įperkamumą gyventojams, todėl ir toliau aktyviai dalyvaus vaistų politikoje ir stebės situaciją vaistų rinkoje.
Malta agrees with the European Commission’s legislative proposals to improve access to medicines and to establish a pharmaceutical common market in the European Union. Talks between Malta’s deputy Prime Minister and Health Minister, Chris Fearne and the EU Commissioner for Health and Food Safety, Stella Kyriakides, focused on the challenges of small markets, such as that of Malta.
Shortages of medicines within the EU and the improved access to innovative medication across the Union, particularly in small markets such as Malta, were the main focus of discussions between Deputy Prime Minister and Minister for Health Chris Fearne and European Commissioner for Health and Food Safety, Stella Kyriakides, during her official visit to Malta.
Medicine shortages within the EU and improved access to innovative medication across the union, particularly in small markets such as Malta, were the main focus of discussions between Health Minister Chris Fearne and European Health Commissioner Stella Kyriakides.
European Commissioner for Health and Food Safety, Stella Kyriakides, along with Christopher Fearne, the Deputy Prime Minister and Minister for Health of Malta, visited the Medichem manufacturing sites as part of the Commissioner’s visit to Malta to speak at the Medicines for Europe Annual Conference. The conference has taken place from the 14th to the 16th of June 2023 and has been a platform for discussing policies and measures that will contribute to the improvement of patient health and the competitive pharmaceutical environment in Europe.